Table 1.
Demographic data of the study population.
| Characteristics | Death group | Survival group | P |
|---|---|---|---|
| N (sample size) | 1042 | 4742 | |
| Baseline variables | |||
| Age (median [IQR]) | 74.88 [60.93,83.99] | 65.53 [52.65,78.47] | < 0.001 |
| Gender (% Male) | 558 (53.6) | 2663 (56.2) | 0.125 |
| Septic shock | 260 (24.9) | 480 (10.1) | < 0.001 |
| Coexisting comorbidities | |||
| Coronary atherosclerotic heart disease | 219 (21.0) | 1117 (23.6) | 0.078 |
| Diabetes | 288 (27.6) | 1342 (28.3) | 0.668 |
| Hypertension | 182 (17.5) | 724 (15.3) | 0.078 |
| Chronic pulmonary disease | 246 (23.6) | 931 (19.6) | 0.004 |
| Renal failure | 219 (21.0) | 825 (17.4) | 0.006 |
| Scoring systems | |||
| LODS (median [IQR]) | 7 [5,9] | 4 [3, 6] | < 0.001 |
| SAPS II (median [IQR]) | 51 [41, 63] | 36 [28, 44] | < 0.001 |
| SIRS (median [IQR]) | 3 [3, 4] | 3 [2, 4] | < 0.001 |
| SOFA (median [IQR]) | 7 [4, 10] | 4 [3, 6] | < 0.001 |